M.L.G. Janssen‐Heijnen

9.2k total citations · 1 hit paper
128 papers, 6.9k citations indexed

About

M.L.G. Janssen‐Heijnen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, M.L.G. Janssen‐Heijnen has authored 128 papers receiving a total of 6.9k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Oncology, 43 papers in Pulmonary and Respiratory Medicine and 31 papers in Pathology and Forensic Medicine. Recurrent topics in M.L.G. Janssen‐Heijnen's work include Global Cancer Incidence and Screening (36 papers), Colorectal Cancer Screening and Detection (26 papers) and Lung Cancer Treatments and Mutations (25 papers). M.L.G. Janssen‐Heijnen is often cited by papers focused on Global Cancer Incidence and Screening (36 papers), Colorectal Cancer Screening and Detection (26 papers) and Lung Cancer Treatments and Mutations (25 papers). M.L.G. Janssen‐Heijnen collaborates with scholars based in Netherlands, United States and Germany. M.L.G. Janssen‐Heijnen's co-authors include J.W.W. Coebergh, Saskia Houterman, V.E.P.P. Lemmens, Huub Maas, Marieke W.J. Louwman, Freddie Bray, Lonneke V. van de Poll‐Franse, Hermann Brenner, Isabelle Soerjomataram and H.J.T. Rutten and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

In The Last Decade

M.L.G. Janssen‐Heijnen

124 papers receiving 6.7k citations

Hit Papers

Global cancer incidence in older adults, 2012 and 2035: A... 2018 2026 2020 2023 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M.L.G. Janssen‐Heijnen Netherlands 45 4.0k 2.0k 1.3k 1.1k 888 128 6.9k
Esther Bastiaannet Netherlands 45 4.5k 1.1× 1.6k 0.8× 1.6k 1.2× 692 0.6× 566 0.6× 263 6.9k
Rosemary Yancik United States 28 3.7k 0.9× 1.4k 0.7× 937 0.7× 738 0.7× 751 0.8× 39 6.7k
Alok A. Khorana United States 69 5.8k 1.4× 2.6k 1.3× 3.7k 2.8× 1.4k 1.3× 1.7k 1.9× 360 20.8k
Riccardo Capocaccia Italy 41 4.6k 1.1× 1.8k 0.9× 1.4k 1.1× 1.3k 1.2× 1.4k 1.6× 126 8.9k
Melinda A. Maggard United States 39 3.2k 0.8× 1.4k 0.7× 4.0k 3.0× 1.4k 1.3× 856 1.0× 82 8.0k
Corneel Coens Belgium 47 3.7k 0.9× 2.6k 1.3× 2.3k 1.8× 352 0.3× 591 0.7× 143 9.0k
Irene Floriani Italy 47 3.3k 0.8× 2.3k 1.1× 1.8k 1.4× 1.2k 1.1× 605 0.7× 159 8.3k
Milena Sant Italy 37 4.5k 1.1× 1.6k 0.8× 1.4k 1.1× 1.4k 1.2× 1.4k 1.5× 126 8.3k
Winson Y. Cheung Canada 36 3.7k 0.9× 1.3k 0.6× 914 0.7× 512 0.5× 511 0.6× 434 5.8k
Franck Bonnetain France 51 6.5k 1.6× 4.2k 2.1× 4.6k 3.5× 822 0.8× 961 1.1× 288 11.2k

Countries citing papers authored by M.L.G. Janssen‐Heijnen

Since Specialization
Citations

This map shows the geographic impact of M.L.G. Janssen‐Heijnen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.L.G. Janssen‐Heijnen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.L.G. Janssen‐Heijnen more than expected).

Fields of papers citing papers by M.L.G. Janssen‐Heijnen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.L.G. Janssen‐Heijnen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.L.G. Janssen‐Heijnen. The network helps show where M.L.G. Janssen‐Heijnen may publish in the future.

Co-authorship network of co-authors of M.L.G. Janssen‐Heijnen

This figure shows the co-authorship network connecting the top 25 collaborators of M.L.G. Janssen‐Heijnen. A scholar is included among the top collaborators of M.L.G. Janssen‐Heijnen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.L.G. Janssen‐Heijnen. M.L.G. Janssen‐Heijnen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wyers, Caroline E., et al.. (2024). The risk of fragility fractures in men with prostate cancer treated with androgen deprivation therapy. Osteoporosis International. 35(11). 2037–2045. 1 indexed citations
3.
Driessen, Elisabeth J.M., et al.. (2019). Population-based patterns of treatment and survival for patients with stage I and II non-small cell lung cancer aged 65–74 years and 75 years or older. Journal of Geriatric Oncology. 10(4). 547–554. 11 indexed citations
4.
Janssen‐Heijnen, M.L.G., et al.. (2016). Epidemiology, management and survival outcomes of primary cutaneous melanoma: a ten-year overview. Acta chirurgica Belgica. 117(1). 29–35. 27 indexed citations
5.
Janssen‐Heijnen, M.L.G., et al.. (2015). Variation in causes of death in patients with non-small cell lung cancer according to stage and time since diagnosis. Annals of Oncology. 26(5). 902–907. 52 indexed citations
6.
Pickhardt, Perry J., et al.. (2014). Sigmoid Cancer versus Chronic Diverticular Disease: Differentiating Features at CT Colonography. Radiology. 275(1). 127–135. 30 indexed citations
7.
Janssen‐Heijnen, M.L.G., et al.. (2013). Tolerance and benefits of treatment for elderly patients with limited small-cell lung cancer. Journal of Geriatric Oncology. 5(1). 71–77. 18 indexed citations
8.
Broek, Esther C. van den, et al.. (2013). Increased risk of chronic lymphocytic leukaemia among cancer survivors in the Netherlands: increased detection, causal factors or both?. Annals of Hematology. 93(1). 157–162. 8 indexed citations
9.
Verhoeven, Rob H.A., M.L.G. Janssen‐Heijnen, Roberto Zanetti, et al.. (2012). Population-based survival of penile cancer patients in Europe and the United States of America: No improvement since 1990. European Journal of Cancer. 49(6). 1414–1421. 61 indexed citations
10.
Janssen‐Heijnen, M.L.G., Huub Maas, Sabine Siesling, et al.. (2011). Treatment and survival of patients with small-cell lung cancer: small steps forward, but not for patients >80. Annals of Oncology. 23(4). 954–960. 19 indexed citations
11.
Veen, Eelco J., et al.. (2009). Pneumonectomy for bronchogenic carcinoma: analysis of factors predicting short- and long-term outcome. Interactive Cardiovascular and Thoracic Surgery. 9(2). 260–264. 9 indexed citations
12.
Gondos, Ádám, Freddie Bray, David Brewster, et al.. (2008). Recent trends in cancer survival across Europe between 2000 and 2004: A model-based period analysis from 12 cancer registries. European Journal of Cancer. 44(10). 1463–1475. 99 indexed citations
13.
Janssen‐Heijnen, M.L.G., Huub Maas, Saskia Houterman, et al.. (2007). Comorbidity in older surgical cancer patients: Influence on patient care and outcome. European Journal of Cancer. 43(15). 2179–2193. 191 indexed citations
14.
Houterman, Saskia, M.L.G. Janssen‐Heijnen, C D G W Verheij, et al.. (2006). Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer and Prostatic Diseases. 9(2). 179–184. 36 indexed citations
15.
Houterman, Saskia, M.L.G. Janssen‐Heijnen, Ad J.M. Hendrikx, H. Berg, & J.W.W. Coebergh. (2005). Impact of comorbidity on treatment and prognosis of prostate cancer patients: A population-based study. Critical Reviews in Oncology/Hematology. 58(1). 60–67. 57 indexed citations
16.
Spronsen, D.J. van, M.L.G. Janssen‐Heijnen, V.E.P.P. Lemmens, W Peters, & J.W.W. Coebergh. (2005). Independent prognostic effect of co-morbidity in lymphoma patients: Results of the population-based Eindhoven Cancer Registry. European Journal of Cancer. 41(7). 1051–1057. 69 indexed citations
17.
Kuper‐Hommel, Marion, Simone Snijder, M.L.G. Janssen‐Heijnen, et al.. (2005). Treatment and Survival of Patients with Thyroid Lymphoma: A Population-Based Study with Clinical and Pathologic Reviews. Clinical Lymphoma & Myeloma. 6(3). 240–247. 7 indexed citations
18.
Janssen‐Heijnen, M.L.G., Gemma Gatta, D Forman, Riccardo Capocaccia, & J.W.W. Coebergh. (1998). Variation in survival of patients with lung cancer in Europe, 1985–1989. European Journal of Cancer. 34(14). 2191–2196. 108 indexed citations
19.
Janssen‐Heijnen, M.L.G., Rob M. Schipper, P J Klinkhamer, et al.. (1998). Divergent changes in survival for histological types of non-small-cell lung cancer in the southeastern area of The Netherlands since 1975. British Journal of Cancer. 77(11). 2053–2057. 14 indexed citations
20.
Coebergh, J.W.W., M.L.G. Janssen‐Heijnen, & P. P. A. Razenberg. (1998). Prevalence of co-morbidity in newly diagnosed patients with cancer: a population-based study. Critical Reviews in Oncology/Hematology. 27(2). 97–100. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026